The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC), scheduled for December 10, 2025, from 8:30 a.m. to 12:00 p.m. BST.

This half-day primer, held at the Queen Elizabeth II Centre in London, UK, focuses on fundamental immuno-oncology (IO) concepts.

The program will cover current and emerging topics in immuno-oncology (IO), including neoadjuvant immunotherapy, intratumoral immunotherapies, recombinant cytokines, and bispecific antibodies, alongside new applications of AI, spatial biology, and multiomic approaches.